Kyto Biopharma, Inc. Announces Management Changes
Corporation. Simon P. Westbrook has been appointed Chief Financial Officer of the Corporation. Peter Prendergast has resigned as Director of the Corporation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | -45.65% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 16.33M | |
+5.64% | 77.82B | |
+1.73% | 63.42B | |
-3.88% | 41.7B | |
-2.28% | 36.09B | |
+0.79% | 33.78B | |
-28.73% | 10.59B | |
+13.54% | 9.9B | |
-31.63% | 7.59B | |
-3.05% | 7.53B |